Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the countries listed. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
AUGTYRO
Class 5 – Pharmaceuticals & supplements
Status timeline
- 21 Feb 2022Application filedNew Application Entered
- 1 Dec 2022Assigned to an examining attorneyAssigned To Examiner
- 2 Dec 2022Office action issuedNon-Final Action Written
- 26 May 2023Response to office action filedTeas Response To Office Action Received
- 28 May 2023Approved for publicationApproved For Pub - Principal Register
- 11 Jul 2023Published for oppositionPublished For Opposition
- 5 Sep 2023Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 26 Feb 2024Statement of use filedTeas Statement Of Use Received
- 7 Apr 2024Statement of use acceptedAllowed Principal Register - Sou Accepted
- 9 Apr 2024Statement of use acceptedNotice Of Acceptance Of Statement Of Use E-Mailed
- 14 May 2024Registered on the Principal RegisterRegistered-Principal Register
All 30 events
| 2024-05-14 | Registered-Principal Register |
| 2024-05-14 | Notice Of Registration Confirmation Emailed |
| 2024-04-09 | Notice Of Acceptance Of Statement Of Use E-Mailed |
| 2024-04-07 | Allowed Principal Register - Sou Accepted |
| 2024-03-18 | Case Assigned To Intent To Use Paralegal |
| 2024-03-18 | Statement Of Use Processing Complete |
| 2024-02-26 | Teas Statement Of Use Received |
| 2024-02-26 | Use Amendment Filed |
| 2023-09-05 | Noa Mailed - Sou Required From Applicant |
| 2023-07-11 | Published For Opposition |
| 2023-07-11 | Official Gazette Publication Confirmation E-Mailed |
| 2023-06-21 | Notification Of Notice Of Publication E-Mailed |
| 2023-06-07 | Electronic Record Review Complete |
| 2023-06-02 | On Hold - Electronic Record Review Required |
| 2023-05-28 | Approved For Pub - Principal Register |
| 2023-05-27 | Teas/Email Correspondence Entered |
| 2023-05-26 | Teas Response To Office Action Received |
| 2023-05-26 | Correspondence Received In Law Office |
| 2022-12-02 | Non-Final Action Written |
| 2022-12-02 | Non-Final Action Written |
| 2022-12-02 | Non-Final Action E-Mailed |
| 2022-12-02 | Notification Of Non-Final Action E-Mailed |
| 2022-12-01 | Assigned To Examiner |
| 2022-09-09 | Teas Change Of Owner Address Received |
| 2022-09-09 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2022-09-09 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2022-09-09 | Teas Change Of Correspondence Received |
| 2022-09-09 | Applicant/Correspondence Changes (Non-Responsive) Entered |
| 2022-02-23 | New Application Office Supplied Data Entered |
| 2022-02-21 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical preparations for the treatment of cancer
First use anywhere 5 Dec 2023 · First use in commerce 5 Dec 2023
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 14 May 2024; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.